Stay updated on EPCORE™ NHL-1 Clinical Trial
Sign up to get notified when there's something new on the EPCORE™ NHL-1 Clinical Trial page.

Latest updates to the EPCORE™ NHL-1 Clinical Trial page
- Check7 days agoChange DetectedSeptember 2026 update dates were added to the study record and August 2026 dates were removed, signaling a revision to the record's update history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNIH Grant/Contract entries for 2017 and 2023 were added to the funding information. The Revision: v3.6.6 entry indicates the page was updated from the prior v3.6.5.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new citation was added to the Publications section, listing authors and the article about epcoritamab dosing and CRS risk mitigation. This broadens the study's referenced literature in the context of ongoing research.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded a new publication citation (Sinnollareddy et al.) related to epcoritamab to the study publications. The page version was updated to v3.6.5, and older July entries were removed to refresh the publication and version history.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, indicating a maintenance release of the site's underlying framework. This does not modify the study details or clinical data presented on the page.SummaryDifference0.0%

- Check71 days agoChange DetectedThe study record's update dates were refreshed with July 2026 entries, replacing June 2026 dates. This appears to be routine maintenance of the page rather than modifications to the trial details.SummaryDifference0.1%

Stay in the know with updates to EPCORE™ NHL-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPCORE™ NHL-1 Clinical Trial page.